Rhonda Farnum Theravance Biopharma, Inc. (TBPH) insider trading activity

TBPH Quotes by TradingView

Rhonda Farnum is SVP, COMM & MEDICAL AFFAIRS of Theravance Biopharma, Inc.. Currently has a direct ownership of 374,038 shares of TBPH, which is worth approximately $3.47 Million. The most recent transaction as insider was on Feb 28, 2022, when has been sold 2,356 shares (Ordinary Shares) at a price of $10.16 per share, resulting in proceeds of $23,937. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 374K
19.29% 3M change
19.99% 12M change
Total Value Held $3.47 Million

Rhonda Farnum Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 28 2022
SELL
Open market or private sale
$23,937 $10.16 p/Share
2,356 Reduced 0.7%
333,271 Ordinary Shares
Feb 18 2022
SELL
Payment of exercise price or tax liability
$113,629 $9.61 p/Share
11,824 Reduced 3.4%
335,627 Ordinary Shares
Dec 14 2021
BUY
Grant, award, or other acquisition
-
27,500 Added 7.33%
347,451 Ordinary Shares
RF

Rhonda Farnum

SVP, COMM & MEDICAL AFFAIRS
South San Francisco, CA

Track Institutional and Insider Activities on TBPH

Follow Theravance Biopharma, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TBPH shares.

Notify only if

Insider Trading

Get notified when an Theravance Biopharma, Inc. insider buys or sells TBPH shares.

Notify only if

News

Receive news related to Theravance Biopharma, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on TBPH